Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MYC inhibitors in multiple myeloma
Sandra Martínez-Martín, Laura Soucek
Cancer Drug Resistance (2021)
Open Access | Times Cited: 18

Showing 18 citing articles:

Demystifying the Druggability of the MYC Family of Oncogenes
Nishant M. Karadkhelkar, Mingliang Lin, Lisa M. Eubanks, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 6, pp. 3259-3269
Closed Access | Times Cited: 22
Strategies to target the cancer driver MYC in tumor cells
Leonie I. Weber, Markus Hartl
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 18
Emerging role of MYB transcription factors in cancer drug resistance
Bernhard Biersack, Michael Höpfner
Cancer Drug Resistance (2024)
Open Access | Times Cited: 5
Role of Non-Coding RNAs in Diagnosis, Prediction and Prognosis of Multiple Myeloma
Maciej Dubaj, Karol Bigosiński, Aleksandra Dembowska, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 1033-1033
Open Access | Times Cited: 4
MYC: Master Regulator of Cell Death and Tumor Progression
Lucia Capasso, Donato Mele, Fatima Fayyaz, et al.
IntechOpen eBooks (2025)
Closed Access
Potent molecular-targeted therapies for gastro-entero-pancreatic neuroendocrine carcinoma
Akira Ooki, Hiroki Osumi, Koshiro Fukuda, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 3, pp. 1021-1054
Open Access | Times Cited: 10
C-terminal binding protein 2 is a novel tumor suppressor targeting the MYC-IRF4 axis in multiple myeloma
Coty Hing Yau Cheung, Chi‐Keung Cheng, Kam Tong Leung, et al.
Blood Advances (2024) Vol. 8, Iss. 9, pp. 2217-2234
Open Access | Times Cited: 3
Multiple myeloma: clinical characteristics, current therapies and emerging innovative treatments targeting ribosome biogenesis dynamics
Mohamed Halaby Elbahoty, Bhavyasree Papineni, Rajeev S. Samant
Clinical & Experimental Metastasis (2024) Vol. 41, Iss. 6, pp. 829-842
Open Access | Times Cited: 3
The de novo DNA methyltransferase 3B is a novel epigenetic regulator of MYC in multiple myeloma, representing a promising therapeutic target to counter relapse
Catharina Muylaert, Lien Ann Van Hemelrijck, Arne Van der Vreken, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
In Silico, In Vitro, and In Vivo Investigations on Adapalene as Repurposed Third Generation Retinoid against Multiple Myeloma and Leukemia
Joelle C. Boulos, Manik Chatterjee, Letian Shan, et al.
Cancers (2023) Vol. 15, Iss. 16, pp. 4136-4136
Open Access | Times Cited: 7
How Driver Oncogenes Shape and Are Shaped by Alternative Splicing Mechanisms in Tumors
Weronika Wojtyś, Magdalena Oroń
Cancers (2023) Vol. 15, Iss. 11, pp. 2918-2918
Open Access | Times Cited: 4
A Systems Biology Analysis of Chronic Lymphocytic Leukemia
Giulia Pozzati, Jinrui Zhou, Hananel Hazan, et al.
Onco (2024) Vol. 4, Iss. 3, pp. 163-191
Open Access | Times Cited: 1
The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma
Arianna Giacomini, Sara Taranto, Giorgia Gazzaroli, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 1
Antisense oligonucleotides-based approaches for the treatment of multiple myeloma
Mădălina Oprea, Mariana Ioniţă
International Journal of Biological Macromolecules (2024) Vol. 291, pp. 139186-139186
Open Access | Times Cited: 1
Cancer drug resistance in multiple myeloma
Fatih M. Uckun
Cancer Drug Resistance (2022)
Open Access | Times Cited: 6
Noncoding RNAs Controlling Oxidative Stress in Cancer
Paul Holvoet
Cancers (2023) Vol. 15, Iss. 4, pp. 1155-1155
Open Access | Times Cited: 3
A Systems Biology Analysis of Chronic Lymphocytic Leukemia
Giulia Pozzati, Jinrui Zhou, Hananel Hazan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Rna-loaded nanoparticles for the treatment of hematological cancers
Elisa Garbayo, Souhaila H. El Moukhtari, Carlos Rodríguez‐Nogales, et al.
Advanced Drug Delivery Reviews (2024) Vol. 214, pp. 115448-115448
Open Access
Page 1

Scroll to top